Annual Cash & Cash Equivalents:
$70.56M-$168.38M(-70.47%)Summary
- As of today, COLL annual cash & cash equivalents is $70.56 million, with the most recent change of -$168.38 million (-70.47%) on December 31, 2024.
- During the last 3 years, COLL annual cash & cash equivalents has fallen by -$115.86 million (-62.15%).
- COLL annual cash & cash equivalents is now -70.47% below its all-time high of $238.95 million, reached on December 31, 2023.
Performance
COLL Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$242.00M+$24.37M(+11.20%)Summary
- As of today, COLL quarterly cash & cash equivalents is $242.00 million, with the most recent change of +$24.37 million (+11.20%) on June 1, 2025.
- Over the past year, COLL quarterly cash & cash equivalents has dropped by -$29.63 million (-10.91%).
- COLL quarterly cash & cash equivalents is now -25.65% below its all-time high of $325.47 million, reached on June 30, 2023.
Performance
COLL Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
COLL Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -70.5% | -10.9% |
| 3Y3 Years | -62.1% | +97.2% |
| 5Y5 Years | -58.5% | +66.1% |
COLL Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -70.5% | at low | -25.6% | +80.4% |
| 5Y | 5-Year | -70.5% | at low | -25.6% | +126.8% |
| All-Time | All-Time | -70.5% | +4218.5% | -25.6% | >+9999.0% |
COLL Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $242.00M(+11.2%) |
| Mar 2025 | - | $217.63M(+15.9%) |
| Dec 2024 | $70.56M(-70.5%) | $187.76M(+29.5%) |
| Sep 2024 | - | $144.96M(-46.6%) |
| Jun 2024 | - | $271.63M(-14.6%) |
| Mar 2024 | - | $318.05M(+2.4%) |
| Dec 2023 | $238.95M(+37.6%) | $310.55M(+2.0%) |
| Sep 2023 | - | $304.56M(-6.4%) |
| Jun 2023 | - | $325.47M(+20.8%) |
| Mar 2023 | - | $269.48M(+55.2%) |
| Dec 2022 | $173.69M(-6.8%) | $173.69M(+29.5%) |
| Sep 2022 | - | $134.13M(+9.3%) |
| Jun 2022 | - | $122.72M(+15.0%) |
| Mar 2022 | - | $106.70M(-42.8%) |
| Dec 2021 | $186.43M(+7.1%) | $186.43M(-3.5%) |
| Sep 2021 | - | $193.24M(-4.7%) |
| Jun 2021 | - | $202.77M(+10.9%) |
| Mar 2021 | - | $182.79M(+5.0%) |
| Dec 2020 | $174.12M(+2.4%) | $174.12M(+5.3%) |
| Sep 2020 | - | $165.42M(+13.6%) |
| Jun 2020 | - | $145.68M(+25.4%) |
| Mar 2020 | - | $116.18M(-31.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $170.02M(+15.9%) | $170.02M(+10.5%) |
| Sep 2019 | - | $153.84M(+3.4%) |
| Jun 2019 | - | $148.71M(+10.2%) |
| Mar 2019 | - | $134.91M(-8.0%) |
| Dec 2018 | $146.63M(+23.5%) | $146.63M(+4.9%) |
| Sep 2018 | - | $139.79M(+4.5%) |
| Jun 2018 | - | $133.75M(+4.3%) |
| Mar 2018 | - | $128.25M(+8.0%) |
| Dec 2017 | $118.70M(-22.5%) | $118.70M(+10.3%) |
| Sep 2017 | - | $107.61M(-3.2%) |
| Jun 2017 | - | $111.21M(-14.2%) |
| Mar 2017 | - | $129.56M(-15.4%) |
| Dec 2016 | $153.22M(+60.1%) | $153.22M(+68.3%) |
| Sep 2016 | - | $91.03M(-17.8%) |
| Jun 2016 | - | $110.75M(-17.8%) |
| Mar 2016 | - | $134.73M(+40.8%) |
| Dec 2015 | $95.70M(+5756.6%) | $95.70M(-9.3%) |
| Sep 2015 | - | $105.46M(-6.2%) |
| Jun 2015 | - | $112.41M(+149.9%) |
| Mar 2015 | - | $44.99M(+2653.3%) |
| Dec 2014 | $1.63M(-78.4%) | $1.63M |
| Dec 2013 | $7.55M | - |
FAQ
- What is Collegium Pharmaceutical, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. annual cash & cash equivalents year-on-year change?
- What is Collegium Pharmaceutical, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. quarterly cash & cash equivalents year-on-year change?
What is Collegium Pharmaceutical, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of COLL is $70.56M
What is the all-time high annual cash & cash equivalents for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high annual cash & cash equivalents is $238.95M
What is Collegium Pharmaceutical, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, COLL annual cash & cash equivalents has changed by -$168.38M (-70.47%)
What is Collegium Pharmaceutical, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of COLL is $242.00M
What is the all-time high quarterly cash & cash equivalents for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high quarterly cash & cash equivalents is $325.47M
What is Collegium Pharmaceutical, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, COLL quarterly cash & cash equivalents has changed by -$29.63M (-10.91%)